scholarly journals The New Elderly Patient: A Necessary Upgrade

Prosthesis ◽  
2021 ◽  
Vol 3 (1) ◽  
pp. 99-104
Author(s):  
Santo Catapano ◽  
Luca Ortensi ◽  
Nicola Mobilio ◽  
Francesco Grande
Keyword(s):  
Elderly Patients ◽  
Social Life ◽  
Dental Treatment ◽  
The Elderly ◽  
Developed Countries ◽  
Average Life Span ◽  
High Expectations ◽  
Dental Management ◽  
Manual Skills

The elderly individual is becoming the most common patient in clinical practice due to the increasing average life span, especially in developed countries. The current elderly patients are different from those of some decades ago. They usually have an active social life, want to be informed, and are actively involved in the current society with consequent high expectations for medical and dental treatment. However, not all the elderly patients are like this. Some of them show limited financial resources, reduced mental and manual skills, and poor motivation. The purpose of this communication is to make a brief characterization of the new elderly population in view of prosthetic and dental management.

Urological Surgery in Elderly Patients: Results and Considerations - Part II

1992 ◽  
Vol 59 (4) ◽  
pp. 31-35 ◽  
Author(s):  
M. Pizzarella ◽  
G. Ferro ◽  
F. Invidiato ◽  
P. Ligato ◽  
M. Fiorello ◽  
...  
Keyword(s):  
Numerical Analysis ◽  
Cardiovascular Diseases ◽  
Elderly Patients ◽  
The Elderly ◽  
Average Life ◽  
Average Life Span ◽  
Urological Surgery ◽  
Incidence And Mortality ◽  
Age Limits ◽  
Surgery In Elderly

It is certainly true that increase of the average life span has caused a greater percentage of elderly people to visit urological departments. From April 1989 to December 1991, patients over 75 years under our observation were 10.8% of all operated patients. Only 5% of patients over 75 who needed to be operated, weren't actually operated. The numerical analysis of our experience has highlighted the fact that in patients who underwent an operation, the incidence and mortality caused by cardiovascular diseases weren't any higher than those found in other people of the same age. We are also convinced that prejudices about age limits should not prevent the elderly afflicted with a benign or malignant urological pathology from undergoing an operation.

Restorative Management of the Elderly Patient

2003 ◽  
Vol os10 (2) ◽  
pp. 45-48 ◽  
Author(s):  
A Graham Gilmour ◽  
Claire L Morgan
Keyword(s):  
Family Relationships ◽  
Dental Treatment ◽  
Age Groups ◽  
The Elderly ◽  
Oral Disease ◽  
Working Lives ◽  
Periodontal Breakdown ◽  
Dental Management ◽  
Younger Age

It is predicted that geriatric patients will dramatically increase in number within our working lives. Although they are considered to demand treatment less frequently than the younger age groups, there are specific issues that need to be considered when providing dental treatment for these patients. The term gerodontics has been coined to describe this subject. The need to consider family relationships and the role of carers may play a greater part in their dental management than that of the general population. As well as oral disease, the incidence of general disease is higher in this population, as is the amount of medication prescribed to treat it; these factors often complicate dental management. Special problems that will have a high dental impact on the geriatric patient may be lack of adaptive potential, poor plaque control, root caries, periodontal breakdown and levels of toothwear.

scholarly journals Az időskori gyógyszerterápia alapjai

2019 ◽  
Vol 160 (23) ◽  
pp. 896-907
Author(s):  
András Telekes ◽  
Dániel Deme
Keyword(s):  
Elderly Patients ◽  
Daily Practice ◽  
The Elderly ◽  
Developed Countries ◽  
Elderly Subjects ◽  
Pharmacokinetics And Pharmacodynamics ◽  
Important Place ◽  
Pharmaceutical Therapy ◽  
The Social ◽  
The Developed Countries

Abstract: The proportion of elderly patients is getting increased in the developed countries as a consequence of which pharmacotherapy takes a more and more important place in the healthcare system. Important biological alterations are characteristic for the elderly subjects, which have effect on the pharmacokinetics and pharmacodynamics of the pharmaceuticals. Gradually decreased kidney function may demand the modification of the administration of the pharmaceuticals. Certain pharmaceuticals and drug-interactions are potentially dangerous for this population. Therefore several factors have to be taken into account in conjunction with the therapy of elderly patients including co-morbidities, cognitive function and the social state. At the same time, the risk–benefit ratio of the pharmaceuticals is the worst among elderly patients with pharmaceutical therapy including polypragmasy. Thus, it is inevitable for the development of geriatric pharmacotherapy that the physiologic alteration of elderly has to be taken into account not only in the daily practice but also during the development and formulation of a pharmaceutical. The present paper gives an overview of the most important factors influencing the pharmacotherapy of the elderly. Orv Hetil. 2019; 160(23): 896–907.

Drug-related problems in the elderly

2012 ◽  
Vol 153 (49) ◽  
pp. 1926-1936 ◽  
Author(s):  
Andrea Bor ◽  
Mária Matuz ◽  
Péter Doró ◽  
Réka Viola ◽  
Gyöngyvér Soós
Keyword(s):  
Elderly Patients ◽  
Financial Burden ◽  
The Elderly ◽  
Developed Countries ◽  
Evidence Based ◽  
Beers Criteria ◽  
Drug Related Problems ◽  
Drug Reactions ◽  
Inappropriate Drugs

The aging population in developed countries is a growing problem nowadays. The burden on healthcare is particularly high, since the prevalence of the diseases, especially chronic diseases increases with age. Prevalence of polypharmacy is common among elderly patients. While comorbidities require usage of several active agents with evidence based indication, polypharmacy increases the likelihood of interactions and adverse drug reactions, reduces patient compliance, affects quality of life and puts a significant financial burden on the patient and society. In order to reduce drug-related problems among the elderly, different lists of potentially inappropriate drugs and doses were created. One of the earliest known lists is the “Beers criteria”. The use of listed drugs is risky and not recommended for elderly patients. Following foreign examples, a list was compiled and adapted to the Hungarian drug spectrum based on the main concerns and alternative therapeutic suggestions. Orv. Hetil., 2012, 153, 1926–1936.

scholarly journals Hearing Outcomes and Complications of Cochlear Implantation in Elderly Patients over 75 Years of Age

2021 ◽  
Vol 10 (14) ◽  
pp. 3123
Author(s):  
Rie Kanai ◽  
Shin-ichi Kanemaru ◽  
Kaoru Tamura ◽  
Yoshiko Noda ◽  
Naomi Umezawa ◽  
...  
Keyword(s):  
Hearing Loss ◽  
Elderly Patients ◽  
The Elderly ◽  
Elderly Group ◽  
Profound Hearing Loss ◽  
Average Life Span ◽  
Open Set ◽  
Major Complications ◽  
Significant Difference ◽  
Surgery In Elderly

Objective: Populations are aging in many countries, and the proportion of elderly people with severe to profound hearing loss is increasing in parallel with the increasing average life span. The objective of this study was to investigate the outcomes of cochlear implant (CI) surgery in elderly patients compared to those in younger patients. Methods: The outcomes of CI surgery were retrospectively investigated for 81 adults (32 men and 49 women) who underwent CI surgery at our hospital. They were divided according to age at the time of implantation into the younger group (<75 years of age; n = 49) or elderly group (≥75 years of age; n = 32). Results: The mean sentence recognition score on the CI-2004 Japanese open-set test battery (±standard deviation) was 82.9% ± 24.1 in the younger group and 81.9% ± 23.2 in the elderly group, with no significant difference between the groups (Mann–Whitney U test). The incidence of major complications that required surgical treatment was not significantly different between the groups (4.1% vs. 6.2%, respectively). Thus, there were no severe complications that could affect general health status in either group. Three patients in each group died for reasons unrelated to CI surgery during follow-up. The proportion of patients who were alive and continued to use the CI five years after surgery was 92.8% and 91.5%, respectively. Conclusion: Our results show good speech recognition and a low incidence of major complications in elderly patients. This comprehensive report on the outcomes of CI surgery in elderly patients will be helpful to the elderly with severe to profound hearing loss when deciding whether to undergo CI surgery.

scholarly journals Acute coronary syndrome in elderly: aspects of patient management

The Clinician ◽  
2019 ◽  
Vol 13 (1-2) ◽  
pp. 19-26 ◽  
Author(s):  
Yu. D. Ryzhkova ◽  
E. V. Kanareykina ◽  
M. R. Atabegashvili ◽  
E. V. Konstantinova ◽  
M. Yu. Gilyarov
Keyword(s):  
Clinical Trials ◽  
Acute Coronary Syndrome ◽  
Elderly Patients ◽  
Randomized Clinical Trials ◽  
The Elderly ◽  
Developed Countries ◽  
Interventional Treatment ◽  
Coronary Syndrome ◽  
Age Related ◽  
Related Association

Coronary heart disease is the leading cause of death worldwide. Over the past few decades, life expectancy has increased, which has led to an aging population in developed countries, so the average age of patients with acute coronary syndrome (ACS) has steadily increased in recent decades. The inclusion of elderly and senile patients in randomized clinical trials does not reflect the age-related association of these diseases. However, antithrombotic therapy and interventional treatment are the basis of treatment in patients with ACS of any age, including the elderly. For older patients, there may be a mismatch between chronological and biological age. The question of how close the treatment of elderly patients with ACS is to the level of current recommendations and whether it is possible to apply them unconditionally in this group of patients does not have a definite answer. Current recommendations and the underlying randomized clinical trials are focused on any one disease, whereas in the elderly in most cases multimorbid pathology occurs. In general, elderly patients with ACS should be treated using the same methods as younger patients, however, the presence of comorbid diseases in an elderly patient naturally increases the risk of complications, makes the patient’s prognosis heavier, significantly affects treatment tactics, limits the possibility of using conventional approaches when choosing a drug therapy.

106 Precipitating factors in the elderly patients admitted with the diagnosis of heart failure. Are easy to find?

2006 ◽  
Vol 5 (1) ◽  
pp. 25-26
Author(s):  
R VIDALPEREZ ◽  
E ABUASSI ◽  
M PARAMODEVEGA ◽  
P VELOSO ◽  
A VARELAROMAN ◽  
...  
Keyword(s):  
Heart Failure ◽  
Elderly Patients ◽  
The Elderly ◽  
Precipitating Factors

Evaluation of R-CHOP and R-CVP in the treatment of elderly patient with non-Hodgkin lymphoma

MedPharmRes ◽  
2019 ◽  
Vol 3 (3) ◽  
pp. 1-6
Author(s):  
Truc Phan ◽  
Tram Huynh ◽  
Tuan Q. Tran ◽  
Dung Co ◽  
Khoi M. Tran
Keyword(s):  
Elderly Patients ◽  
Hodgkin Lymphoma ◽  
B Cell Lymphoma ◽  
Complete Response ◽  
The Elderly ◽  
Free Survival ◽  
Non Hodgkin Lymphoma ◽  
Common Sign ◽  
Related Mortality

Introduction: Little information is available on the outcomes of R-CHOP (rituximab with cyclophosphamide, doxorubicin, vincristine and prednisone) and R-CVP (rituximab with cyclophosphamide, vincristine and prednisone) in treatment of the elderly patients with non-Hodgkin lymphoma (NHL), especially in Vietnam. Material and methods: All patients were newly diagnosed with CD20-positive non-Hodgkin lymphoma (NHL) at Blood Transfusion and Hematology Hospital, Ho Chi Minh city (BTH) between 01/2013 and 01/2018 who were age 60 years or older at diagnosis. A retrospective analysis of these patients was perfomed. Results: Twenty-one Vietnamese patients (6 males and 15 females) were identified and the median age was 68.9 (range 60-80). Most of patients have comorbidities and intermediate-risk. The most common sign was lymphadenopathy (over 95%). The proportion of diffuse large B cell lymphoma (DLBCL) was highest (71%). The percentage of patients reaching complete response (CR) after six cycle of chemotherapy was 76.2%. The median follow-up was 26 months, event-free survival (EFS) was 60% and overall survival (OS) was 75%. Adverse effects of rituximab were unremarkable, treatment-related mortality accounted for less than 10%. There was no difference in drug toxicity between two regimens. Conclusions: R-CHOP, R-CVP yielded a good result and acceptable toxicity in treatment of elderly patients with non-Hodgkin lymphoma. In patients with known cardiac history, omission of anthracyclines is reasonable and R-CVP provides a competitive complete response rate.

Sign in / Sign up

Export Citation Format

Share Document